The Cannabinoid Science Nobody is Talking About (Holiday Encore 3 of 3)
CannaInsider - Interviews with the Business Leaders of The Legal Cannabis, Marijuana, CBD Industry
English - January 04, 2021 10:00 - 43 minutes - 35.7 MB - ★★★★★ - 631 ratingsInvesting Business News Business News dispensary mmj cannabis cannabisseeds dispensaries edibles investing legalization marijuana marijuanaseeds Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
We just reached possibly one of the largest milestones in creating pure, consistent cannabinoids in a lab. Here to tell us about it is Kevin Chen of Hyasynth Bio.
Learn more at https://hyasynthbio.com
Key Takeaways:
[1:32] An inside look at Hyasynth Bio and its work creating biosynthesized cannabis compounds
[3:05] Hyasynth Bio’s first product, an ultra-pure CBD oil created using cultured cannabinoids
[7:44] How Hyasynth Bio is improving CBD production in terms of both speed and purity
[9:12] Why multinational companies are gravitating towards biosynthesized cannabinoids for better consistency and supply chain performance
[16:55] How biosynthesized cannabinoids are paving the way for international cannabis brands and which products Kevin believes will go global first
[21:23] How cellular agriculture is giving us better access to rare cannabinoids
[27:48] Why cellular agriculture is easier to automate and how this might influence prices in the cannabis industry
[32:21] Hyasynth Bio’s strategy to profit primarily through intellectual property licensing
[36:24] Where Hyasynth Bio currently is in the capital-raising process